Cargando…
Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway
Cardiac hypertrophy is accompanied by increased myocardial oxidative stress, and whether naringenin, a natural antioxidant, is effective in the therapy of cardiac hypertrophy remains unknown. In the present study, different dosage regimens (25, 50, and 100 mg/kg/d for three weeks) of naringenin (NAR...
Autores principales: | Li, Yu, He, Bo, Zhang, Chao, He, Yanji, Xia, Tianyang, Zeng, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056776/ https://www.ncbi.nlm.nih.gov/pubmed/36986070 http://dx.doi.org/10.3390/nu15061340 |
Ejemplares similares
-
Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway
por: Chen, Youming, et al.
Publicado: (2020) -
Bellidifolin ameliorates isoprenaline-induced cardiac hypertrophy by the Nox4/ROS signalling pathway through inhibiting BRD4
por: Zhou, Dingyan, et al.
Publicado: (2023) -
Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway
por: Qian, Weichun, et al.
Publicado: (2018) -
Isosteviol prevents the development of isoprenaline-induced myocardial hypertrophy
por: Chen, Yaoxu, et al.
Publicado: (2019) -
Soluble adenylyl cyclase: A novel player in cardiac hypertrophy induced by isoprenaline or pressure overload
por: Schirmer, Ilona, et al.
Publicado: (2018)